StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLAW) stock

ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.00 (-2.08%)

Close on Nov 18, 2026Market cap $14.48MP/E –Yield –

Estrella Immunopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Estrella Immunopharma

Estrella Immunopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Estrella Immunopharma figures

See a number that looks wrong?